Effect of BMI on Cardiovascular Risk in Rheumatoid Arthritis Varies by Antibody Status and Biologic Use
Body mass index influenced cardiovascular risk in rheumatoid arthritis, with [...]
Advancing Equity in Electrophysiology: Don’t Miss ABC’s Featured Session at HRS 2025
ABC is proud to lead a vital conversation at the [...]
Watch Now: Empowering Preeclampsia Survivors for Lifelong Heart Health
Did you miss the recent webinar, Strong Hearts, Bright Futures: Empowering [...]
Congratulations to the Winner of the ABC Best Abstract Competition at ACC.25!
The ABC is thrilled to announce Sheriff Dodoo, MD, of the [...]
Empowering Communities Through Digital Health: The Techquity by FAITH! Digital Health Advocate Training
Transforming Lives with Digital Health Advocacy The Mayo Clinic’s FAITH! [...]
Amgen Announces Robust Weight Loss With Maritide In People Living With Obesity Or Overweight At 52 Weeks In A Phase 2 Study
MariTide Demonstrated up to ~20% Average Weight Loss at 52 [...]
Attruby™ (acoramidis), a Near Complete TTR Stabilizer (≥90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients
– Attruby is the first and only approved product with a [...]
Open-Label Extension Data Confirms Sustained Benefit of Acoramidis on Cardiovascular Outcomes, Including Statistically Significant Reduction in ACM Within 36 Months
Acoramidis demonstrated the earliest known time to separation in cardiovascular [...]